[Do phosphodiesterase type 5 inhibitors generics enhance discontinuation due to price with patients suffering from erectile dysfunction?]

CONCLUSION: Patients treated with generic PDE5i are as unobservant as those treated with brand-name PDE5i.
LEVEL OF EVIDENCE: 3.
PMID: 31151915 [PubMed - as supplied by publisher]

Source: Progres en Urologie - June 5, 2019 Category: Urology & Nephrology Tags: Prog Urol Source Type: research